Barriers to the successful treatment of liver disease by hepatocyte transplantation. - Wikidata - wikimedia - TriplyDB

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

http://www.wikidata.org/entity/Q34091618

about

Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts Liver-Regenerative Transplantation: Regrow and Reset Hepatic progenitor cells in canine and feline medicine: potential for regenerative strategies Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation Hepatic radiation toxicity: avoidance and amelioration In vitro culture of functionally active buffalo hepatocytes isolated by using a simplified manual perfusion method In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase.Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Single liver lobe repopulation with wildtype hepatocytes using regional hepatic irradiation cures jaundice in Gunn rats.Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.A whole-organ regenerative medicine approach for liver replacement.Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.Magnetic cell labeling of primary and stem cell-derived pig hepatocytes for MRI-based cell tracking of hepatocyte transplantation.Hepatocyte culture in autologous decellularized spleen matrix.In Situ Transplantation of Alginate Bioencapsulated Adipose Tissues Derived Stem Cells (ADSCs) via Hepatic Injection in a Mouse Model Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases.Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation.Perspectives on whole-organ assembly: moving toward transplantation on demand.Use of Magnetocapsules for In Vivo Visualization and Enhanced Survival of Xenogeneic HepG2 Cell Transplants Improvement of Infusion Process in Cell Transplantation: Effect of Shear Stress on Hepatocyte Viability Under Horizontal and Vertical Syringe Orientation.Monitoring of Liver Cell Transplantation in a Preclinical Swine Model Using Magnetic Resonance Imaging.A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer.Cellular therapy and bioartificial approaches to liver replacement Generation of functional hepatocytes from human spermatogonial stem cells.Human hepatic progenitor cells express hematopoietic cell markers CD45 and CD109.Parent perspectives on decisions to participate in a phase I hepatocyte transplant trial.Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells.Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro.The road to regenerative liver therapies: the triumphs, trials and tribulations.Liver support strategies: cutting-edge technologies.Assembly of human organs from stem cells to study liver disease.Cell and tissue engineering for liver disease.Preparing the ground for tissue regeneration: from mechanism to therapy.Functionalizable silica-based micron-sized iron oxide particles for cellular magnetic resonance imaging.Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells External inosculation as a feature of revascularization occurs after free transplantation of murine liver grafts.Potential barriers to human hepatocyte transplantation in MUP-uPAtg(⁺/⁺)Rag2⁻/⁻γC⁻/⁻ mice.A ZFN/piggyBac step closer to autologous liver cell therapy.

P2860

Q21131741-BB9C2E53-6E92-4FEC-96A0-12B0309C8C0B Q26772154-0EB3CE58-20A6-41F2-A0F6-08EFDD98D2C7 Q26823828-2646C2F0-7924-4DE7-91FE-9C6E23928997 Q27001113-8C2A3550-BCE9-4D39-B595-8C8AE6B2955F Q27023687-A3C1FD87-E870-413A-81F0-D2C647E02E6D Q28544688-9127E8C3-AC8D-49D5-8DAE-08DF4713BB0F Q31003888-4023E7E2-E807-4428-BA12-6604CD3FFB7E Q33818431-4CE2461C-03B7-43A5-8B8B-28C218763D8B Q34455103-C0979FFE-A960-4BDB-A59E-12E6FF2B6E79 Q34966816-6A46A8A4-9931-463F-BD3F-893917E99978 Q35010089-73C7E77E-46B4-4944-BAB1-7C27D1960A1D Q35087066-41EFC40A-2C43-4533-8983-E654FD621804 Q35347689-EBA27F4A-D802-4DFC-9315-316D91F71462 Q35558171-DC13ADD2-FE86-461F-90C1-5B7783B2A28A Q35776326-86512D9E-2085-423D-8EDE-3482A12E74E4 Q35917970-7B7C1785-FFB2-4461-9BCF-F1DE690EAC94 Q35990789-39AC487F-0F5A-4B8C-8E48-D17DA8972054 Q36095585-FF07BE2E-B896-43B5-B3C2-8AD98AC3AE52 Q36357819-9BC590D1-67E9-4D49-A4CC-3AF1FC520BC4 Q36501873-F19363C5-7FA3-495A-B7C9-A1A7FDA1EE7E Q36523489-165D58FD-4208-4C15-8744-D11B99CBF972 Q36680593-02C4B2B2-0254-49AB-A29E-9EAED1CE0529 Q36765305-DC5C94D4-D137-4424-BBFC-DD8CE3DC54D2 Q36925733-D3174170-4177-4C46-85AC-4CC89783EE69 Q36929640-667A8136-0961-456C-AFF1-CC7975512676 Q36962440-05993BD2-0909-4FC2-A4EC-B01849E5E123 Q37434280-5D6BE472-4A0B-4991-8822-BDD66B48D64B Q37498874-11D9EB80-7721-47B0-8C6D-CB62EED817BD Q37501605-F5497F05-847F-4B6D-BD1E-FB3DABF606FB Q37710737-2412BF60-CF88-49E3-B77D-30B192966779 Q38140492-3362D97F-BE63-41D3-97AB-FEEDA1A64385 Q38156043-9CDC260A-3B5F-4B6F-A429-65A91267B6AA Q38170868-58D89A38-6181-4296-9D21-1B859F391A7E Q38230357-DFEB43AE-699A-4991-954E-5F6BA226E7B5 Q38237617-AAEA8829-E0A6-44BA-9160-23E57D59D8A5 Q39490394-4F2A7BC2-83D7-46D4-BD9C-8B15EF0F34BE Q41863865-A70024F9-72B6-423D-8D65-89F2287B1B09 Q44738565-780483EB-566E-4383-B307-14CE7A769271 Q45741378-AC75C75D-9638-40B7-B0C0-2406B85E0C4A Q46026523-48CB5EFF-4F83-4035-86C5-85A969D51E94

P2860

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

http://www.wikidata.org/entity/Q34091618

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@ast

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@en

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@nl

type

label

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@ast

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@en

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@nl

prefLabel

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@ast

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@en

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@nl

P1433

Q34091618-41C5AF05-CA0D-4F54-B20E-7943C28D9BE7

P1476

Q34091618-B69A2D1D-7040-446A-A681-21B05A5EF1DC

P2093

Q34091618-03ADF808-0A5E-4730-81EC-379F2E19977C

Q34091618-211A0584-FF53-4299-AA79-3F6ACA3FA4B0

Q34091618-2B70253C-6A9B-4735-A424-307EABA9C5BE

Q34091618-31B9AE59-596E-4EDE-BA89-93F2022AC2C1

Q34091618-4FAA7199-F41B-4FB7-8374-5BBFE5ECB45D

Q34091618-9AC94729-9E7A-4913-8D71-C2B662363886

Q34091618-B615D040-0A0F-4484-9A69-4B85C7935154

Q34091618-C85E19E9-4563-4261-985E-81950837087F

Q34091618-CACCA9A1-1A03-4F9B-AAF6-0002931AD68A

Q34091618-CF62E190-8882-4307-BEE2-CF342D8E3F0F

P2860

Q34091618-058BF969-5D4E-48A2-8F53-7D307225FC0C

Q34091618-0F7398F2-5880-4862-83ED-E589873434F1

Q34091618-18D21A0C-A001-456D-A423-9F41479F0236

Q34091618-190E0628-43FC-475E-8535-DFA5FA81C013

Q34091618-1C2192AB-05DD-4444-AEBA-4FC74B1BFA60

Q34091618-1DEEB093-D645-463F-A64B-BD260361A98A

Q34091618-25173D02-ECCC-42CA-A4C6-5C5DBC05FB10

Q34091618-26C4DB85-C6C7-4EFB-B1A0-D12B4B80D7AC

Q34091618-277C0C72-3E4E-41F0-9FD9-8788462B8A2A

Q34091618-36B8A814-1A25-4D29-ABF3-67E92ED68F37

P304

Q34091618-B1B641BB-A6BC-4EC8-974F-7CFD3C6332CA

P31

Q34091618-6495B5EF-F34F-43E2-BEA7-C933FBDFA0D1

P356

Q34091618-585941ED-DD9B-4393-BCAE-D524CDD8CF54

P433

Q34091618-47225553-3FF1-4069-A576-118B7EC87C23

P478

Q34091618-DE36B223-E5B7-4B7F-9788-06AFDE85A69A

P50

Q34091618-767B5A6A-F3C7-485C-AF0E-AD5217ED368D

Q34091618-ACD9798F-E203-444C-B812-935C07E08AEC

Q34091618-D9FE6B3F-65F4-4B93-9CDD-7F456990D2BD

P577

Q34091618-A87E6C09-3562-45E1-A103-CBB9C3FC67B8

P5875

Q34091618-DFFDB575-A24A-4C48-9EE5-2018F62DE005

P698

Q34091618-5B6C5205-A5CC-4C16-AC91-D1C314BAA5B9

P932

Q34091618-234C09EA-8095-4D1E-B155-D7EF2BE3391D

P356

J.JHEP.2010.05.010

P1433

Journal of Hepatology

P1476

Barriers to the successful treatment of liver disease by hepatocyte transplantation.

@en

P2093

Alejandro Soto-Gutiérrez

http://www.w3.org/2001/XMLSchema#string

Benjamin L Shneider

http://www.w3.org/2001/XMLSchema#string

Chandan Guha

http://www.w3.org/2001/XMLSchema#string

Ira J Fox

http://www.w3.org/2001/XMLSchema#string

Jayanta Roy-Chowdhury

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Platt

http://www.w3.org/2001/XMLSchema#string

Kyle A Soltys

http://www.w3.org/2001/XMLSchema#string

Masaki Nagaya

http://www.w3.org/2001/XMLSchema#string

Melvin Deutsch

http://www.w3.org/2001/XMLSchema#string

Robert Squires

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart

Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation

Human induced pluripotent stem cells free of vector and transgene sequences

Liver support technology--an update.

Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates.

Hepatocyte transplantation for the treatment of human disease.

Animal models of fulminant hepatic failure: a critical evaluation.

Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction.

Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations.

P304

769-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2010.05.010

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Stephen C Strom

Kevin M. Baskin

P577

2010-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45405995

http://www.w3.org/2001/XMLSchema#string

P698

20667616

http://www.w3.org/2001/XMLSchema#string

P932

2930077

http://www.w3.org/2001/XMLSchema#string